|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.04 EUR | -1.42% |
|
+6.98% | -35.20% |
| 15/05 | GRIFOLS : In line Q1 and on track deleveraging; worth a go |  |
| 14/05 | Grifols, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
BARCELONA (Reuters) - Grifols said on Monday its executive chairman Thomas Glanzmann will become its new chief executive with immediate effect, ending the founding family's executive leadership at a time of turmoil within the Spanish pharmaceutical group.
Glanzmann, who had served as the board's vice chairman since 2017, was appointed chairman in February after Steven F. Mayer resigned as Grifols' executive chairman due to health and other personal reasons.
(Reporting by Joan Faus; Editing by David Latona)
| 1st Jan change | Capi. | |
|---|---|---|
| -35.20% | 662.56Cr | |
| +0.10% | 9.14TCr | |
| +2.76% | 4.11TCr | |
| -9.06% | 3.43TCr | |
| +54.44% | 2.53TCr | |
| -16.61% | 1.53TCr | |
| -9.14% | 1.28TCr | |
| -12.11% | 1.16TCr | |
| -43.61% | 1.14TCr | |
| +4.72% | 915.59Cr |
GRIFOLS, S.A. 
